Bellicum Pharmaceuticals, Inc.

MUN:BPXA Stock Report

Market Cap: €772.4k

Bellicum Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of BPXA?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders116,8410.961%
Institutions450,1013.7%
Hedge Funds3,443,93128.3%
General Public8,152,64867%

Dilution of Shares: Insufficient data to determine if shareholders have been diluted in the past year.


Top Shareholders

Top 11 shareholders own 32.97% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.5%
Baker Bros. Advisors LP
2,365,472€150.2k0%no data
8.87%
Armistice Capital LLC
1,078,459€68.5k12.8%no data
3.68%
Ikarian Capital, LLC
448,101€28.5k0%0.01%
0.18%
Jon Stonehouse
22,054€1.4k0%no data
0.16%
Reid Huber
19,494€1.2k0%no data
0.15%
Stephen Davis
18,715€1.2k0%no data
0.12%
Judith Klimovsky
14,602€927.20%no data
0.12%
Charity Scripture
14,587€926.20%no data
0.12%
James Daly
14,377€913.00%no data
0.11%
Richard Fair
13,012€826.30%no data
0.016%
Wetzel Investment Advisors, Inc.
2,000€127.00%no data